| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Nov 20, 2024 | Stephens Kristin Chief Development Officer | Sell | Syros Pharmaceuticals, Inc. | SYRS | $0.22 | $7,949 | -0 |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.